Paper · 42939746
Serum Cytokine Profiling in Pancreatic Ductal Adenocarcinoma: A Pilot Study of Candidate Discriminators, Sex Differences and Altered Co-Regulation.
García-Gómez J and 9 others. Biomolecules, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Serum Cytokine Profiling in Pancreatic Ductal Adenocarcinoma: A Pilot Study of Candidate Discriminators, Sex Differences and Altered Co-Regulation. Papers, record 42939746. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42939746
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum Cytokine Profiling in Pancreatic Ductal Adenocarcinoma: A Pilot Study of Candidate Discriminators, Sex Differences and Altered Co-Regulation.
- Journal
- Biomolecules
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-28
Source PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Pancreatic Ductal | Major topic |
| Cytokines | Major topic |
| Pancreatic Neoplasms | Major topic |
| Humans | |
| Male | |
| Female | |
| Aged | |
| Pilot Projects | |
| Middle Aged | |
| Interleukin-7 | |
| Biomarkers, Tumor | |
| Sex Characteristics | |
| Sex Factors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| FIS/IMSS/PROT/PRIO/19/103 | Mexican Social Security Institute | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,159,120 | Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35159120 | PubMed |
| 2 | 30,106,639 | Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/30106639 | PubMed |
| 3 | 36,091,056 | Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients. | Front Immunol | 2022 | https://conductscience.org/library/papers/36091056 | PubMed |
| 4 | 37,857,666 | Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma. | Commun Med (Lond) | 2023 | https://conductscience.org/library/papers/37857666 | PubMed |
| 5 | 23,637,840 | Negative association between testosterone concentration and inflammatory markers in young men: a nested cross-sectional study. | PLoS One | 2013 | https://conductscience.org/library/papers/23637840 | PubMed |
| 6 | 35,850,192 | An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. | Gastroenterology | 2022 | https://conductscience.org/library/papers/35850192 | PubMed |
| 7 | 34,366,606 | Pancreatic cancer: A review of epidemiology, trend, and risk factors. | World J Gastroenterol | 2021 | https://conductscience.org/library/papers/34366606 | PubMed |
| 8 | 29,290,757 | Mortality assessment of patients with pancreatic cancer in Mexico, 2000-2014. | Ecancermedicalscience | 2017 | https://conductscience.org/library/papers/29290757 | PubMed |
| 9 | 17,192,050 | Multianalyte profiling of serum cytokines for detection of pancreatic cancer. | Cancer Biomark | 2005 | https://conductscience.org/library/papers/17192050 | PubMed |
| 10 | 20,210,523 | Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis. | Cancer Invest | 2010 | https://conductscience.org/library/papers/20210523 | PubMed |
1 to 10 of 68
See all 68 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42939746
GET https://conductscience.org/api/papers/v1/42939746/references?page=2